Y. Makino

发表

Novel Endogenous 1,2,3,4‐Tetrahydroisoquinoline Derivatives: Uptake by Dopamine Transporter and Activity to Induce Parkinsonism

S. Ohta, M. Hirobe, Y. Makino, 1998, Journal of neurochemistry.

1‐Benzyl‐1,2,3,4‐Tetrahydroisoquinoline as a Parkinsonism‐Inducing Agent: A Novel Endogenous Amine in Mouse Brain and Parkinsonian CSF

S. Ohta, Y. Kotake, M. Hirobe, 1995, Journal of neurochemistry.

1‐Methyl‐ 1,2,3,4‐Tetrahydroisoquinoline, Decreasing in 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Treated Mouse, Prevents Parkinsonism‐Like Behavior Abnormalities

S. Ohta, M. Hirobe, Y. Tasaki, 1991, Journal of neurochemistry.

Identification and quantification of p-hydroxyethylamphetamine as a novel metabolite of ethylamphetamine in rat by gas chromatography-mass spectrometry.

S. Ohta, M. Hirobe, T. Higuchi, 1989, Forensic science international.

Confirmation of the enantiomers of 1-methyl-1,2,3,4-tetrahydroisoquinoline in the mouse brain and foods applying gas chromatography/mass spectrometry with negative ion chemical ionization.

S. Ohta, M. Hirobe, Y. Tasaki, 1990, Biomedical & environmental mass spectrometry.

Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.

S. Ohta, M. Hirobe, Y. Tasaki, 1990, Life sciences.

Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.

K. Kikuchi, S. Ohta, T. Mashino, 1991, Drug metabolism and disposition: the biological fate of chemicals.

Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease.

S. Ohta, M. Hirobe, Y. Makino, 1988, Life sciences.

[The simultaneous determination of Ara-U and Ara-C, urinary metabolites of N4-behenoyl-1-beta-D-arabinofuranosylcytosine by mass fragmentography (author's transl)].

K. Watanabe, Y. Makino, M. Hirobe, 1982, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Biosynthesis of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), a possible antiparkinsonism agent.

S. Ohta, M. Hirobe, Y. Tasaki, 1993, Advances in neurology.

TETRAHYDROISOQUINOLINE AND l-METHYL-TETRAHYDROISOQUINOLINE ARE PRESENT IN THE HUMAN BRAIN : RELATION TO PARKINSON ’ S DISEASE

S. Ohta, Y. Makino, O. Tachikawa, 2015 .